Earnings summaries and quarterly performance for AMN HEALTHCARE SERVICES.
Executive leadership at AMN HEALTHCARE SERVICES.
Board of directors at AMN HEALTHCARE SERVICES.
Research analysts who have asked questions during AMN HEALTHCARE SERVICES earnings calls.
MM
Mark Marcon
Baird
6 questions for AMN
Also covers: ADP, ASGN, DAY +13 more
Trevor Romeo
William Blair
6 questions for AMN
Also covers: ASGN, CCRN, CWST +9 more
AR
Albert Rice
UBS
3 questions for AMN
Also covers: ACHC, AMED, BTSG +21 more
CD
Constantine Davides
Citizens JMP
3 questions for AMN
Also covers: ADUS, CCRN, CERT +9 more
JS
Jack Slevin
Jefferies Financial Group Inc.
3 questions for AMN
Also covers: AGL, ASTH, ATGE +10 more
JG
Joanna Gajuk
Bank of America
3 questions for AMN
Also covers: ACHC, ADC, ADUS +22 more
KF
Kevin Fischbeck
Bank of America
3 questions for AMN
Also covers: ARDT, CCRN, CI +9 more
Tobey Sommer
Truist Securities, Inc.
3 questions for AMN
Also covers: AMTM, ASGN, BAH +26 more
AR
A.J. Rice
UBS
2 questions for AMN
Also covers: ACHC, ADUS, BTSG +14 more
Brian Tanquilut
Jefferies
2 questions for AMN
Also covers: ACHC, ADUS, AHCO +31 more
Jeffrey Silber
BMO Capital Markets
2 questions for AMN
Also covers: ASGN, ATGE, BFAM +19 more
JS
Jeff Silber
BMO
2 questions for AMN
Also covers: FA, LAUR, STRA
AR
A.J. Rice
UBS Group AG
1 question for AMN
Also covers: ACHC, AMED, BTSG +21 more
Jasper Bibb
Truist Securities
1 question for AMN
Also covers: ABM, APEI, APG +15 more
RG
Ryan Griffin
BMO Capital Markets
1 question for AMN
Also covers: ASGN, COUR, EFX +5 more
TS
Toby Sommer
Truist
1 question for AMN
Also covers: CACI, GFL, SAIC
WS
William Sutherland
The Benchmark Company
1 question for AMN
Also covers: AONC, BEAT, CCRN +10 more
Recent press releases and 8-K filings for AMN.
AMN Healthcare Announces Fourth Quarter and Full Year 2025 Results and Q1 2026 Outlook
AMN
Earnings
Guidance Update
Demand Weakening
- AMN Healthcare reported Q4 2025 revenue of $748.2 million and a GAAP loss of ($0.20) per share, with adjusted EPS of $0.22.
- For the full year 2025, the company recorded revenue of $2,730.4 million, a GAAP loss of ($2.48) per share, and adjusted EPS of $1.36.
- The company reduced debt by $75 million in Q4 2025, contributing to a full-year debt reduction of $285 million.
- Q4 2025 financial results exceeded expectations due to better nurse and allied staffing, including revenue from a large labor disruption event, which also led to travel nurse volume growing 5% sequentially.
- For Q1 2026, consolidated revenue is projected to be between $1.225 billion and $1.240 billion, with an anticipated adjusted EBITDA margin of 9.7% to 10.2%, including approximately $600 million in labor disruption revenue.
Feb 20, 2026, 1:13 AM
AMN Healthcare Reports Q4 2025 Results and Provides Q1 2026 Guidance
AMN
Earnings
Guidance Update
Revenue Acceleration/Inflection
- AMN Healthcare reported full year 2025 revenue of $2.73 billion and Adjusted EBITDA of $234 million, while reducing debt by $285 million.
- For the fourth quarter of 2025, consolidated revenue was $748 million, representing a 2% increase from the prior year, with $124 million attributed to labor disruption revenue.
- The company projects Q1 2026 consolidated revenue to be in the range of $1.225 billion to $1.24 billion, which includes approximately $600 million related to labor disruption support.
- Q1 2026 guidance also anticipates an Adjusted EBITDA margin of 9.7%-10.2% and a gross margin between 23.5% and 24%.
- Management expects Allied, International, and Search businesses to return to year-over-year growth in Q1 2026, with other businesses following in subsequent quarters, and projects sustainable organic revenue growth of 4%-6% per year after 2026.
Feb 19, 2026, 10:00 PM
AMN Healthcare Services Reports Q4 2025 Results and Provides Q1 2026 Outlook
AMN
Earnings
Guidance Update
Revenue Acceleration/Inflection
- AMN Healthcare Services reported Q4 2025 revenue of $748 million, which was 2% higher than the year-ago quarter and $18 million above the high end of guidance. For the full year 2025, revenue was $2.73 billion and Adjusted EBITDA was $234 million.
- Labor disruption revenue was a significant factor, totaling $124 million in Q4 2025 and is anticipated to be approximately $600 million in Q1 2026, which will reduce consolidated gross margin.
- For Q1 2026, the company projects consolidated revenue to be in the range of $1.225 billion-$1.24 billion and an Adjusted EBITDA margin between 9.7%-10.2%.
- The company expects to return all businesses to growth in 2026 and sees a path to delivering sustainable organic revenue growth of 4%-6% per year (excluding labor disruption) and 10%-15% growth of Adjusted EBITDA after 2026.
- AMN reduced debt by $285 million in 2025 and ended the year with a net leverage ratio of 3.3x, with expectations to be below 3x on an LTM basis in Q1 2026.
Feb 19, 2026, 10:00 PM
AMN Healthcare Services Reports Q4 2025 Results and Provides Q1 2026 Guidance
AMN
Earnings
Guidance Update
Revenue Acceleration/Inflection
- AMN Healthcare Services reported Q4 2025 revenue of $748 million, which was 2% higher than the year-ago quarter and $18 million above the high end of guidance. For the full year 2025, revenue was $2.73 billion and Adjusted EBITDA was $234 million.
- The company reduced debt by $285 million in 2025, ending the year with total debt of $775 million and a net leverage ratio of 3.3x, with expectations to be below 3x on an LTM basis in Q1 2026.
- Labor disruption revenue significantly impacted results, reaching $124 million in Q4 2025 and projected to be approximately $600 million in Q1 2026, which reduces consolidated gross margin but drives operating leverage.
- For Q1 2026, consolidated revenue is projected to be in a range of $1.225 billion to $1.24 billion, with an Adjusted EBITDA margin expected between 9.7% and 10.2%.
- AMN expects to return all businesses to growth in 2026, with Allied International and search anticipated to return to year-over-year growth in Q1, and projects 4%-6% sustainable organic revenue growth per year beyond 2026 (excluding labor disruption).
Feb 19, 2026, 10:00 PM
AMN Healthcare Services Reports Q4 2025 Results and Provides Q1 2026 Guidance
AMN
Earnings
Guidance Update
Revenue Acceleration/Inflection
- AMN Healthcare Services reported Q4 2025 revenue of $748.2 million, exceeding its guidance, with consolidated revenue growing 1.8% year-over-year.
- For Q4 2025, the company posted a net loss of $7.7 million and diluted EPS of ($0.20), while Adjusted EBITDA reached $54.5 million with a 7.3% Adjusted EBITDA margin, which was at the high end of its guidance range.
- The company generated $68 million in Free Cash Flow during Q4 2025 and reported a Net Debt Leverage Ratio of 3.3:1 as of December 31, 2025.
- For Q1 2026, AMN anticipates consolidated revenue between $1,225 million and $1,240 million, with an Adjusted EBITDA margin projected to be between 9.7% and 10.2%. The Nurse & Allied Solutions segment is expected to see a significant year-over-year revenue increase of 137% to 139% in Q1 2026.
Feb 19, 2026, 10:00 PM
AMN Healthcare Announces Fourth Quarter and Full Year 2025 Results
AMN
Earnings
Guidance Update
Revenue Acceleration/Inflection
- AMN Healthcare reported Q4 2025 revenue of $748.2 million and adjusted diluted EPS of $0.22. For the full year 2025, revenue was $2,730.4 million and adjusted diluted EPS was $1.36.
- The company generated $76 million in cash flow from operations for Q4 2025 and $269 million for the full year, and reduced debt by $285 million in 2025.
- Consolidated revenue for Q4 2025 increased 2% year-over-year, reaching $748 million, with Nurse and Allied Solutions revenue up 8% year-over-year driven by better staffing results, including $124 million from a large labor disruption event.
- For Q1 2026, AMN Healthcare projects consolidated revenue between $1.225 billion and $1.240 billion, representing a 78-80% increase year-over-year, largely due to an anticipated $600 million in labor disruption revenue.
Feb 19, 2026, 9:15 PM
AMN Healthcare Announces Fourth Quarter and Full Year 2025 Results
AMN
Earnings
Guidance Update
- AMN Healthcare reported fourth quarter 2025 revenue of $748.2 million, a 2% increase over the prior year, and adjusted diluted EPS of $0.22.
- For the full year 2025, consolidated revenue was $2.730 billion, an 8% decrease from the prior year, with adjusted diluted EPS of $1.36.
- The company reduced its total debt by $285 million in 2025, ending the year with $775 million in total debt outstanding.
- AMN Healthcare provided first quarter 2026 guidance, projecting consolidated revenue between $1.225 billion and $1.240 billion and an adjusted EBITDA margin between 9.7% and 10.2%.
Feb 19, 2026, 9:15 PM
AMN Healthcare Services Presents Q4 2025 Outlook and Long-Term Growth Strategy
AMN
Guidance Update
Revenue Acceleration/Inflection
Earnings
- AMN Healthcare Services reported $2.7 billion in LTM revenue and $255 million in Adjusted EBITDA as of September 30, 2025.
- For Q4 2025, the company projects an annualized run rate (excluding a large labor disruption event) of $2.5 billion in revenue, with a gross margin of ~27% and an Adjusted EBITDA margin of ~6%.
- Looking into 2026, AMN anticipates 50-100 basis points improvement in both consolidated gross margin and Adjusted EBITDA margin, with specific segments like International Nurse expected to see 15-20% year-over-year growth.
- The company's long-term growth model, beyond 2026, targets 4-6% annual organic revenue growth and a 10-15% CAGR for Adjusted EBITDA.
- As of September 30, 2025, total debt stood at $850 million, with a net leverage ratio of 1.0x.
Jan 14, 2026, 2:01 PM
AMN Healthcare Reports Q3 2025 Results and Issues Q4 2025 Guidance
AMN
Earnings
Guidance Update
Demand Weakening
- AMN Healthcare reported Q3 2025 consolidated revenue of $634.5 million, which was above the high end of its guidance range.
- The company's Adjusted EBITDA for Q3 2025 was $57.5 million, with an Adjusted EBITDA Margin of 9.1%, also exceeding guidance.
- Net income for Q3 2025 was $29.3 million, resulting in earnings per share of $0.76. This income included a $39 million gain on the sale of Smart Square.
- For Q4 2025, AMN Healthcare projects consolidated revenue between $715 million and $730 million, with an Adjusted EBITDA Margin guidance of 6.8% to 7.3%.
Nov 6, 2025, 10:00 PM
AMN Reports Q3 2025 Results and Provides Q4 2025 Guidance
AMN
Earnings
Guidance Update
Revenue Acceleration/Inflection
- Q3 2025 consolidated revenue reached $634 million, with adjusted earnings per share (EPS) at $0.39.
- For Q4 2025, AMN projects consolidated revenue between $715 million and $730 million and an adjusted EBITDA margin of 6.8%-7.3%.
- The company completed a debt refinancing in early October, extending its earliest debt expiration to 2029 and strengthening its financial position.
- Looking to 2026, AMN expects a more favorable revenue mix, with international nurse revenue projected to increase by over 20% and VMS revenue anticipated to turn positive, contributing to higher consolidated gross margins.
- Demand for travel nurses has shown significant recovery, increasing approximately 50% from its mid-May low, while allied demand is now flat year-over-year.
Nov 6, 2025, 10:00 PM
Quarterly earnings call transcripts for AMN HEALTHCARE SERVICES.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more